The landscape and therapeutic relevance of cancer-associated transcript fusions

Yoshihara, K, Wang, Q, Torres-Garcia, W, Zheng, S, Vegesna, R, Kim, H, Verhaak, R G W·2015·Oncogene
DOI 10.1038/onc.2014.406

Cited by (450)

Items 201–300 of 450

  1. Integrative molecular profiling identifies a novel cluster of estrogen receptor‐positive breast cancer in very young women
    Charny Park, Kyong‐Ah Yoon, Ji‐Hyun Kim, In Hae Park, Soo Jin Park, Min Kyeong Kim, Wooyeong Jang, Soo Young Cho, Boyoung Park, Sun‐Young Kong et al. · 2019 · Cancer Science
  2. Statistical algorithms improve accuracy of gene fusion detection
    Gillian L. Hsieh, Rob Bierman, Linda A. Szabo, Alex Gia Lee, Donald E. Freeman, Nathaniel K. Watson, Alejandro Sweet-Cordero, Julia Salzman · 2017 · Nucleic Acids Research
  3. The fusion landscape of hepatocellular carcinoma
    Chengpei Zhu, Yanling Lv, Liangcai Wu, Jinxia Guan, Xue Bai, Jianzhen Lin, Tingting Liu, Haohai Zhang, Anqiang Wang, Xie Yu’an et al. · 2019 · Molecular Oncology
  4. Proteogenomics for understanding oncology: recent advances and future prospects
    Yashwanth Subbannayya, Sneha Maria Pinto, Harsha Gowda, Thottethodi Subrahmanya Keshava Prasad · 2015 · Expert Review of Proteomics
  5. Practical aspects of NGS-based pathways analysis for personalized cancer science and medicine
    Ekaterina A. Kotelnikova, Mikhail A. Pyatnitskiy, A. G. Paleeva, Olga S. Kremenetskaya, D. V. Vinogradov · 2016 · Oncotarget
  6. Anaplastic lymphoma kinase L1198F and G1201E mutations identified in anaplastic thyroid cancer patients are not ligand-independent
    Jikui Guan, Georg Wolfstetter, Joachim T. Siaw, Damini Chand, Fredrik Hugosson, Ruth Helen Palmer, Bengt Hallberg · 2016 · Oncotarget
  7. Long Read Single-Molecule Real-Time Sequencing Elucidates Transcriptome-Wide Heterogeneity and Complexity in Esophageal Squamous Cells
    Yinwei Cheng, Yunmei Chen, Qianqian Zhao, Xing Zhao, Ya-Ru Wu, Danze Chen, Lian‐Di Liao, Yang Chen, Qian Yang, Li‐Yan Xu et al. · 2019 · Frontiers in Genetics
  8. Potential pathogenetic link between angiomyofibroblastoma and superficial myofibroblastoma in the female lower genital tract based on a novel MTG1-CYP2E1 fusion
    Ryosuke Tajiri, Eisuke Shiba, Ryuji Iwamura, Chisachi Kubo, Aya Nawata, Hiroshi Harada, Kiyoshi Yoshino, Masanori Hisaoka · 2021 · Modern Pathology
  9. Genomic and clinical findings in myeloid neoplasms with PDGFRB rearrangement
    Danika Di Giacomo, Martina Quintini, Valentina Pierini, Fabrizia Pellanera, Roberta La Starza, Paolo Gorello, Caterina Matteucci, Barbara Crescenzi, Paolo Fabio Fiumara, Marinella Veltroni et al. · 2021 · Annals of Hematology
  10. Novel COL4A1‐VEGFD gene fusion in myofibroma
    Guillaume Dachy, Sylvie Fraitag, Boutaina Boulouadnine, Sabine Cordi, Jean‐Baptiste Demoulin · 2021 · Journal of Cellular and Molecular Medicine
  11. Melanocytic Myxoid Spindle Cell Tumor With ALK Rearrangement (MMySTAR)
    Émilie Perron, Daniel Pissaloux, Céline Charon‐Barra, Marie Karanian, Laurence Lamant, Sophie Parfait, Laurent Alberti, Arnaud de la Fouchardière · 2017 · The American Journal of Surgical Pathology
  12. High expression of the vacuole membrane protein 1 (VMP1) is a potential marker of poor prognosis in HER2 positive breast cancer
    Arsalan Amirfallah, Aðalgeir Arason, Hjörleifur Einarsson, Eydis Th. Gudmundsdottir, Edda Sigríður Freysteinsdóttir, Kristrún Ólafsdóttir, Óskar Þór Jóhannsson, Bjarni Agnar Agnarsson, Rosa Bjork Barkardottir, Inga Reynisdóttir · 2019 · PLoS ONE
  13. Analysis of fusion transcripts indicates widespread deregulation of snoRNAs and their host genes in breast cancer
    Helena Persson, Rolf Søkilde, Jari Häkkinen, Johan Vallon‐Christersson, Felix Mitelman, Åke Borg, Mattias Höglund, Carlos Rovira · 2020 · International Journal of Cancer
  14. Emerging Role of Genomic Rearrangements in Breast Cancer: Applying Knowledge from Other Cancers
    Bhavna Paratala, Sonia C. Dolfi, Hossein Khiabanian, Lorna Rodríguez-Rodríguez, Shridar Ganesan, Kim Marie Hirshfield · 2016 · Biomarkers in Cancer
  15. Elucidation of Novel Therapeutic Targets for Breast Cancer with ESR1-CCDC170 Fusion
    Jae Heon Jeong, Jae Won Yun, Ha-Young Kim, Chan Yeong Heo, Sejoon Lee · 2021 · Journal of Clinical Medicine
  16. MetaFusion: a high-confidence metacaller for filtering and prioritizing RNA-seq gene fusion candidates
    Michael J. Apostolides, Yue Jiang, Mia Husić, Robert Siddaway, Cynthia E Hawkins, Andrei L. Turinsky, Michael Brudno, Arun K Ramani · 2021 · Bioinformatics
  17. Novel K6-K14 keratin fusion enhances cancer stemness and aggressiveness in oral squamous cell carcinoma
    Fuu‐Jen Tsai, Ming‐Tsung Lai, Jack Cheng, Stev Chun-Chin Chao, Praveen Kumar Korla, Hui‐Jye Chen, Chung-Ming Lin, Ming‐Hsui Tsai, Chun‐Hung Hua, Chia‐Ing Jan et al. · 2019 · Oncogene
  18. ProTECT—Prediction of T-Cell Epitopes for Cancer Therapy
    Arjun Arkal Rao, Ada A. Madejska, Jacob Pfeil, Benedict Paten, Sofie R. Salama, David H. Haussler · 2020 · Frontiers in Immunology
  19. Factors Impacting Clinically Relevant RNA Fusion Assays Using Next-Generation Sequencing
    Nisha Subhashchandra Ramani, Keyur Pravinchandra Patel, Mark J. Routbort, Hector Alvarez, Russell R. Broaddus, Hui Chen, Asif Rashid, Alex J. Lazar, Francis Anthony San Lucas, Hui Yao et al. · 2021 · Archives of Pathology & Laboratory Medicine
  20. Discovery of a rare GKAP1-NTRK2 fusion in a pediatric low-grade glioma, leading to targeted treatment with TRK-inhibitor larotrectinib
    Lily Deland, Simon Keane, Thomas Olsson Bontell, Helene Sjögren, Henrik Fagman, Ingrid Øra, Esther A. De La Cuesta, Magnus Tisell, Jonas A. Nilsson, Katarina Ejeskär et al. · 2021 · Cancer Biology & Therapy
  21. TEX10 Promotes the Tumorigenesis and Radiotherapy Resistance of Urinary Bladder Carcinoma by Stabilizing XRCC6
    Sheng Luo, Wenjin Wang, Jingfang Feng, Rui Li · 2021 · Journal of Immunology Research
  22. Experimentally Deduced Criteria for Detection of Clinically Relevant Fusion 3′ Oncogenes from FFPE Bulk RNA Sequencing Data
    Elizaveta Rabushko, Maxim Sorokin, Maria Suntsova, Alexander P. Seryakov, Denis Kuzmin, Elena V Poddubskaya, Anton A. Buzdin · 2022 · Biomedicines
  23. TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence
    Gongwei Wu, Noriaki Yoshida, Jihe Liu, Xiaoyang Zhang, Yuan Xiong, Tayla B. Heavican, Elisa Mandato, Huiyun Liu, Geoffrey M. Nelson, Lu Yang et al. · 2023 · Science Translational Medicine
  24. Fusion Challenges in Solid Tumors: Shaping the Landscape of Cancer Care in Precision Medicine
    Jibran Ahmed, Carlos Torrado, Anca Chelariu-Raicu, Sunhee Kim, Jordi Ahnert Rodon · 2024 · JCO Precision Oncology
  25. Identification of a novel fusion gene HMGA2‐EGFR in glioblastoma
    Akiyoshi Komuro, Erna Raja, Caname Iwata, Manabu Soda, Kazunobu Isogaya, Keiko Yuki, Yasushi Ino, Masato Morikawa, Tomoki Todo, Hiroyuki Aburatani et al. · 2017 · International Journal of Cancer
  26. The CTNNBIP1-CLSTN1 fusion transcript regulates human neocortical development
    Min‐Yi Ou, Qi Xiao, Xiang-Chun Ju, Peng-Ming Zeng, Jing Huang, Ai-Li Sheng, Zhen‐Ge Luo · 2021 · Cell Reports
  27. Domain retention in transcription factor fusion genes and its biological and clinical implications: a pan-cancer study
    Pora Kim, Leomar Y. Ballester, Zhongming Zhao · 2017 · Oncotarget
  28. Accurate fusion transcript identification from long- and short-read isoform sequencing at bulk or single-cell resolution
    Qian Qin, Victoria Popic, Kirsty Wienand, Houlin Yu, Emily White, Akanksha Khorgade, Asa Shin, Christophe Georgescu, Catarina D. Campbell, Arthur Dondi et al. · 2025 · Genome Research
  29. SVExpress: identifying gene features altered recurrently in expression with nearby structural variant breakpoints
    Yiqun Zhang, Fengju Chen, Chad J. Creighton · 2021 · BMC Bioinformatics
  30. Re-Evaluate Fusion Genes in Prostate Cancer
    Ting Wei, Lu Ji, Tao Ma, Haojie Huang, Jean-Pierre A. Kocher, Liguo Wang · 2021 · Cancer Informatics
  31. FaNDOM: Fast nested distance-based seeding of optical maps
    Siavash R. Dehkordi, Jens Luebeck, Vineet Bafna · 2021 · Patterns
  32. ZNF507 affects TGF-β signaling via TGFBR1 and MAP3K8 activation in the progression of prostate cancer to an aggressive state
    Wookbong Kwon, Seong‐Kyoon Choi, Dae-Hwan Kim, Hyeon‐Gyeom Kim, Jin‐Kyu Park, Jee Eun Han, Gil‐Jae Cho, Sungho Yun, Wookyung Yu, Se‐Hyeon Han et al. · 2021 · Journal of Experimental & Clinical Cancer Research
  33. Novel transcription-induced fusion RNAs in prostate cancer
    Sen Zhao, Marthe Løvf, Kristina Totland Carm, Anne Cathrine Bakken, Andreas Hoff, Rolf Inge Skotheim · 2017 · Oncotarget
  34. Functional comparison of exome capture-based methods for transcriptomic profiling of formalin-fixed paraffin-embedded tumors
    Kyrillus Samaan Shohdy, Rohan Bareja, Michael Sigouros, David C. Wilkes, Princesca Dorsaint, Jyothi Manohar, Daniel Bockelman, Jenny Xiang, Rob Kim, Kentaro Ohara et al. · 2021 · npj Genomic Medicine
  35. Analysis of CD74 Occurrence in Oncogenic Fusion Proteins
    2023
  36. Genomics-Enabled Precision Medicine for Cancer
    Alison Roos, Sara Ann Byron · 2019 · Cancer treatment and research
  37. t(4;12)(q12;p13) ETV6-rearranged AML without eosinophilia does not involve PDGFRA: relevance for imatinib insensitivity
    Sarah B. Mueller, Paola Dal Cin, Long P. Le, Dora C. Dias-Santagata, Jochen K. Lennerz, Anthony John Iafrate, Hetal D. Marble, Andrew Mark Brunner, Matthew J. Weinstock, Marlise Rachael Luskin et al. · 2021 · Blood Advances
  38. Implementing targeted therapies in the treatment of glioblastoma: Previous shortcomings, future promises, and a multimodal strategy recommendation
    Vincent Fougner, Benedikte Hasselbalch, Ulrik Lassen, Joachim Weischenfeldt, Hans Skovgaard Poulsen, Thomas Haargaard Urup · 2022 · Neuro-Oncology Advances
  39. Enhancement of Gene Editing and Base Editing with Therapeutic Ribonucleoproteins through In Vivo Delivery Based on Absorptive Silica Nanoconstruct
    Seongchan Kim, You Kyeong Jeong, Chang Sik Cho, SeokHoon Lee, Chang Ho Sohn, Jeong Hun Kim, Youngdo Jeong, Dong Hyun Jo, Sangsu Bae, Hyojin Lee · 2022 · Advanced Healthcare Materials
  40. New chimeric RNAs in acute myeloid leukemia
    Florence Rufflé, Jerome Audoux, Anthony Boureux, Sacha Beaumeunier, Jean‐Baptiste Gaillard, Elias Bou Samra, André Mégarbané, Bruno Cassinat, Christine Chomienne, Ronnie Cley de Oliveira Alves et al. · 2017 · F1000Research
  41. Identification of a Novel Oncogenic Fusion Gene SPON1-TRIM29 in Clinical Ovarian Cancer That Promotes Cell and Tumor Growth and Enhances Chemoresistance in A2780 Cells
    Saya Nagasawa, Kazuhiro Ikeda, Daisuke Shintani, Chiujung Yang, Satoru Takeda, Kosei Hasegawa, Kuniko Horie, Satoshi Inoue · 2022 · International Journal of Molecular Sciences
  42. Comprehensive drug response profiling and pan-omic analysis identified therapeutic candidates and prognostic biomarkers for Asian cholangiocarcinoma
    Supawan Jamnongsong, Patipark Kueanjinda, Pongsakorn Buraphat, Phuwanat Sakornsakolpat, Kulthida Vaeteewoottacharn, Seiji Okada, Siwanon Jirawatnotai, Somponnat Sampattavanich · 2022 · iScience
  43. C16ORF70/MYTHO promotes healthy aging in C.elegans and prevents cellular senescence in mammals
    Anaïs Franco‐Romero, Valeria Morbidoni, Giulia Milan, Roberta Sartori, Jesper Wulff, Vanina Romanello, Andrea Armani, Leonardo Salviati, Maria Conte, Stefano Salvioli et al. · 2024 · Journal of Clinical Investigation
  44. Pure Apocrine Intraductal Carcinoma of Salivary Glands: Reassessment of Molecular Underpinnings and Behavior
    Luvy Delfin, Jan Johannes Doff, Jeffrey Gagan, Allen B. Flack, Jeffrey F. Krane, Vickie Y. Jo, Alan G. Torell, Doreen N. Palsgrove, Justin A. Bishop · 2024 · Head and Neck Pathology
  45. GraphChrom: A Novel Graph-Based Framework for Cancer Classification Using Chromosomal Rearrangement Endpoints
    Golrokh Mirzaei · 2022 · Cancers
  46. Target-dependent RNA polymerase as universal platform for gene expression control in response to intracellular molecules
    Shodai Komatsu, Hirohisa Ohno, Hirohide Saito · 2023 · Nature Communications
  47. Oncogenic Effect of the Novel Fusion Gene VAPA-Rab31 in Lung Adenocarcinoma
    Daseul Yoon, Kieun Bae, Jin-Hee Kim, Yang‐Kyu Choi, Kyong‐Ah Yoon · 2019 · International Journal of Molecular Sciences
  48. Fusion transcripts and their genomic breakpoints in polyadenylated and ribosomal RNA–minus RNA sequencing data
    Youri Hoogstrate, Malgorzata A. Komor, René Böttcher, Job van Riet, Harmen J.G. van de Werken, Stef van Lieshout, Ralf Hoffmann, Evert van den Broek, Anne S. Bolijn, Natasja F. J. Dits et al. · 2021 · GigaScience
  49. Novel fusion genes and chimeric transcripts in ependymal tumors
    Thale Kristin Olsen, Ioannis Panagopoulos, Ludmila Gorunova, Francesca Micci, Kristin Andersen, Hege Kilen Andersen, Torstein Ragnar Meling, Bernt Johan Due‐Tønnessen, David Scheie, Sverre Heim et al. · 2016 · Genes Chromosomes and Cancer
  50. Clinical Implications and Treatment Strategies for ESR1 Fusions in Hormone Receptor-Positive Metastatic Breast Cancer: A Case Series
    Jamie O. Brett, Lauren L. Ritterhouse, Erik T. Newman, Kelly Edwards Irwin, Megan Dawson, Lianne Y. Ryan, Laura M. Spring, Miguel N. Rivera, Jochen K. Lennerz, Dora C. Dias-Santagata et al. · 2022 · The Oncologist
  51. PRKC Fusion Melanocytic Tumors, a Subgroup of Melanocytic Tumors More Closely Aligned to Blue Nevi Than to PRKAR1A-inactivated Pigmented Epithelioid Melanocytomas
    Pragi Patel, Alice P. Chen, Natasha Sharma, Yongzhan Zhang, Victor Li Quan, Shantel Olivares, Pedram Gerami · 2024 · The American Journal of Surgical Pathology
  52. TAP: a targeted clinical genomics pipeline for detecting transcript variants using RNA-seq data
    Readman Chiu, Ka Ming Nip, Justin Chu, İnanç Birol · 2018 · BMC Medical Genomics
  53. A long-term survivor of pediatric midline glioma with H3F3A K27M and BRAF V600E double mutations
    Yoshiko Nakano, Kai Yamasaki, Hiroaki Sakamoto, Yasuhiro Matsusaka, Noritsugu Kunihiro, Hiroko Fukushima, Takeshi Inoue, Mai Honda‐Kitahara, Junichi Hara, Akihiko Yoshida et al. · 2019 · Brain Tumor Pathology
  54. RAP80 suppresses the vulnerability of R-loops during DNA double-strand break repair
    Takaaki Yasuhara, Reona Kato, Motohiro Yamauchi, Yuki Uchihara, Lee Zou, Kiyoshi Miyagawa, Atsushi Shibata · 2022 · Cell Reports
  55. FARE-CAFE: a database of functional and regulatory elements of cancer-associated fusion events
    Praveen Kumar Korla, Jack Cheng, Chien‐Hung Huang, Jeffrey J. P. Tsai, Yu-Hsuan Liu, Nilubon Kurubanjerdjit, Wen‐Tsong Hsieh, Huey-Yi Chen, Ka‐Lok Ng · 2015 · Database
  56. Gene of the month: DDIT3
    Julio Alexander Díaz-Pérez, Darcy A. Kerr · 2023 · Journal of Clinical Pathology
  57. Evaluation of BIRC6 Expression in Oral Squamous Cell Carcinoma, Epithelial Dysplasia, Lichen Planus with and without Dysplasia, and Hyperkeratosis
    Fateme Eskandari, Alireza Razavian, Razieh Zare, Shayan Ejlali, Alireza Razmahang, Milad Zanjani, Seyedeh Sara Aghili, Mohammad Amin Mahdiyar, Hossein Mofidi, Kamyar Abbasi et al. · 2023 · Diagnostics
  58. Opportunities and Challenges of Small Molecule Inhibitors in Glioblastoma Treatment: Lessons Learned from Clinical Trials
    Linde Hoosemans, Marc Vooijs, Ann Hoeben · 2024 · Cancers
  59. Combined EGFR/ALK Expression Analysis in Laryngeal Squamous Cell Carcinoma
    Anastasia Politi, Evangelos Tsiambas, NICHOLAS S. MASTRONIKOLIS, Dimitrios Peschos, Ioannis Asproudis, Efthymios Kyrodimos, Ilianna E Armata, Aristeidis Chrysovergis, ASIMAKIS D. ASIMAKOPOULOS, VASILEIOS S. PAPANIKOLAOU et al. · 2019 · In Vivo
  60. A Pilot Study for the Feasibility of Exome-Sequencing in Circulating Tumor Cells Versus Single Metastatic Biopsies in Breast Cancer
    Pushpinder Kaur, Daniel Campo, Tania Bibiana Porras, Alexander Ring, Janice M. Lu, Yvonne Chairez, Yunyun Su, Irene M. Kang, Julie E. Lang · 2020 · International Journal of Molecular Sciences
  61. Neoplasia-associated Chromosome Translocations Resulting in Gene Truncation
    Ioannis Panagopoulos, Sverre Heim · 2022 · Cancer Genomics & Proteomics
  62. Computational identification of micro-structural variations and their proteogenomic consequences in cancer
    Yen-Yi Lin, Alexander Gawronski, Faraz Hach, Sujun Li, Ibrahim Numanagić, Iman Sarrafi, Swati Mishra, Andrew McPherson, Colin C. Collins, Milan Radovich et al. · 2017 · Bioinformatics
  63. Complete Response to Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET Fusion–Positive Breast Cancer
    Satomi Watanabe, Masayuki Takeda, Tomoyuki Otani, Takeshi Yoshida, Kazuko Sakai, Elizabeth A. Olek, Stephen Michael Rothenberg, Jennifer F. Kherani, Pearl Plernjit French, Kazuto Nishio et al. · 2021 · JCO Precision Oncology
  64. Whole-genome characterization of myoepithelial carcinomas of the soft tissue
    Joanna Cyrta, Joel A. Rosiene, Rohan Bareja, Sarah Kudman, Wael Al Zoughbi, Samaneh A Motanagh, David C. Wilkes, Kenneth Eng, Tuo Zhang, Evan Sticca et al. · 2022 · Molecular Case Studies
  65. Assessment of MYC Gene and WNT Pathway Alterations in Early-Onset Colorectal Cancer Among Hispanic/Latino Patients Using Integrated Multi-Omics Approaches
    Francisco Carranza, Brigette Waldrup, Yuxin Jin, Yonatan Amzaleg, Mackenzie D. Postel, David Wesley Craig, John David Carpten, Bodour Salhia, D Hernandez, N Gutierrez et al. · 2024 · medRxiv
  66. Recurrent UBE3C-LRP5 translocations in head and neck cancer with therapeutic implications
    Bhasker Dharavath, Ashwin B. Butle, Akshita Chaudhary, Ankita Pal, Sanket Desai, Aniket Chowdhury, Rahul A. Thorat, Pawan Upadhyay, Sudhir Vasudevan Nair, Amit Dutt · 2024 · npj Precision Oncology
  67. Benzene exposure and pediatric leukemia: From molecular clues to epidemiological insights
    Nancy Reynoso‐Noverón, Miguel Santibáñez-Andrade, Juan Torres, Yanueh Bautista-Ocampo, Yesennia Sánchez-Pérez, Claudia María García-Cuellar · 2024 · Toxicology Letters
  68. Identification of STRBP as a Novel JAK2 Fusion Partner Gene in a Young Adult With Philadelphia Chromosome-Like B-Lymphoblastic Leukemia
    Xinyue Zhang, Haiping Dai, Zheng Li, Jia Yin, Xingping Lang, Chunxiao Yang, Sheng Xiao, Mingqing Zhu, Dandan Liu, Hong Liu et al. · 2021 · Frontiers in Oncology
  69. Gene fusions in tumourigenesis with particular reference to ovarian cancer
    Yi Zhou, Mona A El-Bahrawy · 2021 · Journal of Medical Genetics
  70. Oncogenic Activity of Solute Carrier Family 45 Member 2 and Alpha‐Methylacyl‐Coenzyme A Racemase Gene Fusion Is Mediated by Mitogen‐Activated Protein Kinase
    Zehua Zuo, Yan‐Ping Yu, Bao‐Guo Ren, Silvia Liu, Joel B. Nelson, Zhou Wang, Junyan Tao, Tirthadipa Pradhan‐Sundd, Rohit Bhargava, George K. Michalopoulos et al. · 2021 · Hepatology Communications
  71. Fusion proteins in lung cancer: addressing diagnostic problems for deciding therapy
    Federica Zito Marino, Greta Alì, Francesco Facchinetti, Luisella Righi, Gabriella Fontanini, Giulio Rossi, Renato Franco · 2021 · Expert Review of Anticancer Therapy
  72. Profiling Receptor Tyrosine Kinase Fusions in Chinese Breast Cancers
    Zhonghua Tao, Jianxia Liu, Ting Li, Hong Xu, Kai Chen, Jian Zhang, Hao Zhou, Jie Sun, Jinming Han, Zhaoji Guo et al. · 2021 · Frontiers in Oncology
  73. Role and Involvement of TENM4 and miR-708 in Breast Cancer Development and Therapy
    Giulia Peppino, Federica Riccardo, Maddalena Arigoni, Elisabetta Bolli, Giuseppina Barutello, Federica Cavallo, Elena Quaglino · 2022 · Cells
  74. RUNX1 truncation resulting from a cryptic and novel t(6;21)(q25;q22) chromosome translocation in acute myeloid leukemia: A case report
    Ioannis Panagopoulos, Synne Torkildsen, Ludmila Gorunova, Aina Ulvmoen, Anne Maria Tierens, Bernward Zeller, Sverre Heim · 2016 · Oncology Reports
  75. Real-World Clinical Performance of a DNA-Based Comprehensive Genomic Profiling Assay for Detecting Targetable Fusions in Nonsquamous NSCLC
    Philip C. Mack, Rachel B. Keller-Evans, Gerald Li, Katherine T Lofgren, Alexa Betzig Schrock, Sally E. Trabucco, Justin M. Allen, Khaled A. Tolba, Geoffrey R. Oxnard, Richard S.P. Huang · 2024 · The Oncologist
  76. Beyond Hybrid Morphology: A Large Series of Fusion-Driven Benign Peripheral Nerve Sheath Tumors Including 5 Tumors With Novel Fusions
    Carina Anja Dehner, Tania Platero-Portillo, George Jour, Carla Saoud, Yanming Zhang, Darya G. Buehler, Meera Hameed, Michael Michal, Darcy A. Kerr, Klaus Johannes BUSAM et al. · 2025 · Modern Pathology
  77. Landscape of Chimeric RNAs in Non-Cancerous Cells
    Chen Chen, Samuel Haddox, Yue Tang, Fujun Qin, Hui Li · 2021 · Genes
  78. Susceptibility of cytoskeletal-associated proteins for tumor progression
    Abiola Abdulrahman Ayanlaja, Xiaoliang Hong, Bo Cheng, Han Zhou, Kouminin Kanwore, Piniel Alphayo Kambey, Lin Zhang, Chuanxi Tang, Muinat Moronke Adeyanju, Dianshuai Gao · 2021 · Cellular and Molecular Life Sciences
  79. Maximizing Small Biopsy Patient Samples: Unified RNA-Seq Platform Assessment of over 120,000 Patient Biopsies
    P. Sean Walsh, Yangyang Hao, Jie Ding, Jianghan Qu, Jonathan I. Wilde, Ruochen Jiang, Richard T. Kloos, Jing Huang, Giulia Catignani Kennedy · 2022 · Journal of Personalized Medicine
  80. The Efficacy of Molecular Analysis in the Diagnosis of Bone and Soft Tissue Sarcoma: A 15-Year Mono-Institutional Study
    Stefania Benini, Gabriella Gamberi, Stefania Cocchi, Giovanna Magagnoli, Angela Rosa Fortunato, Enrica Sciulli, Alberto Righi, Marco Gambarotti · 2022 · International Journal of Molecular Sciences
  81. Identification of novel cyclin gene fusion transcripts in endometrioid ovarian carcinomas
    Antonio Agostini, Marta Brunetti, Ben Davidson, Claes Goran Trope, Sverre Heim, Ioannis Panagopoulos, Francesca Micci · 2018 · International Journal of Cancer
  82. Using the Seven Bridges Cancer Genomics Cloud to Access and Analyze Petabytes of Cancer Data
    Raunaq Malhotra, Isheeta Seth, Erik M Lehnert, Jing Zhao, Gaurav N. Kaushik, Elizabeth H. Williams, Anurag Sethi, Brandi N. Davis‐Dusenbery · 2017 · Current Protocols in Bioinformatics
  83. CCDC6, a gene product in fusion with different protoncogenes, as a potential chemotherapeutic target
    Aishwarya Laxmi, Pawan Kumar Gupta, Jeena Gupta · 2019 · Cancer Biomarkers
  84. Vulvar Pigmented Epithelioid Melanocytoma With a Novel HTT-PKN1 Fusion: A Case Report
    Michele Donati, Liubov Kastnerova, Dana Cempírková, Tomáš Vaněček, Michal Michal, Dmitry V. Kazakov · 2020 · American Journal of Dermatopathology
  85. Rare and novel RUNX1 fusions in myeloid neoplasms: A single‐institute experience
    Umut Aypar, JinJuan Yao, Dory Londono, Rose Khoobyar, Angela Scalise, Maria E. Arcila, Mikhail Roshal, Wenbin Xiao, Yanming Zhang · 2020 · Genes Chromosomes and Cancer
  86. A fusion of CD63–BCAR4 identified in lung adenocarcinoma promotes tumorigenicity and metastasis
    Kieun Bae, Jin Hee Kim, Hyojik Jung, Sun‐Young Kong, Yun‐Hee Kim, Sunshin Kim, Geon Kook Lee, Jin Soo Lee, Jake June-Koo Lee, Young Seok Ju et al. · 2020 · British Journal of Cancer
  87. Low Prevalence of ETV6::RUNX1 Fusion Gene in a Hispanic Population
    Minerva Mata‐Rocha, Angélica Rangel-López, Elva Jiménez‐Hernández, Juan Carlos Núñez-Enríquez, Blanca Angélica Morales-Castillo, Norberto Sánchez-Escobar, Omar Alejandro Sepúlveda Robles, Juan Carlos Bravata-Alcántara, Alan Steve Nájera-Cortés, Maria Luisa Pérez‐Saldívar et al. · 2022 · Frontiers in Pediatrics
  88. Evaluating gene fusions in solid tumors – Clinical experience using an RNA based 53 gene next-generation sequencing panel
    Pavalan Selvam, Kevin Kelly, Andrew Hesse, Daniel Spitzer, Honey V. Reddi · 2019 · Cancer Genetics
  89. Transcriptome analysis reveals overlap in fusion genes in a phase I clinical cohort of TNBC and HGSOC patients treated with buparlisib and olaparib
    Julia Eismann, Yujing Jan Heng, Johannes Moritz Waldschmidt, Ioannis S. Vlachos, Kathryn P. Gray, Ursula A. Matulonis, Panagiotis A. Konstantinopoulos, Charles J. Murphy, Sheida Nabavi, Gerburg M. Wulf · 2019 · Journal of Cancer Research and Clinical Oncology
  90. The Fusion Gene Landscape in Taiwanese Patients with Non-Small Cell Lung Cancer
    Ya‐Sian Chang, Siang-Jyun Tu, Ju-Chen Yen, Ya-Ting Lee, Hsin‐Yuan Fang, Jan‐Gowth Chang · 2021 · Cancers
  91. Multi-omic characterization of ILC and ILC-like cell lines as part of ILC cell line encyclopedia (ICLE) defines new models to study potential biomarkers and explore therapeutic opportunities
    Osama Shiraz Shah, Fangyuan Chen, Abdalla M. Wedn, Anokhi Kashiparekh, Beth A. Knapick, Jian Chen, Laura Savariau, Ben Clifford, Jagmohan Hooda, Matthias Christgen et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  92. p160 nuclear receptor coactivator family members and their role in rare fusion‑driven neoplasms (Review)
    Danilo Segovia, Polona Šafarič Tepeš · 2024 · Oncology Letters
  93. Enhanced Detection of Novel Low‐Frequency Gene Fusions via High‐Yield Ligation and Multiplexed Enrichment Sequencing
    Yi Wu, Jinxiao Guo, Wenjun Li, Xuehao Xiu, Deepak Thirunavukarasu, Yudong Wang, Kai Wang, Weiyu Chen, David Yu Zhang, Xiurong Yang et al. · 2024 · Angewandte Chemie International Edition
  94. Recurrent TRAK1::RAF1 Fusions in pediatric low‐grade gliomas
    Jamal K. Benhamida, Hannah J. Harmsen, Deqin Ma, Christopher M. William, Bryan K. Li, Liliana B. Villafania, Purvil Sukhadia, Kerry A. Mullaney, Michael Christopher Dewan, Efsevia Vakiani et al. · 2023 · Brain Pathology
  95. FusionPro, a Versatile Proteogenomic Tool for Identification of Novel Fusion Transcripts and Their Potential Translation Products in Cancer Cells*
    Chae-Yeon Kim, Keun Na, Saeram Park, Seul-Ki Jeong, Jin-Young Cho, Heon Shin, Min Jung Lee, Gyoonhee Han, Young‐Ki Paik · 2019 · Molecular & Cellular Proteomics
  96. A Poorly Differentiated Non-keratinizing Sinonasal Squamous Cell Carcinoma with a Novel ETV6-TNFRSF8 Fusion Gene
    Justin Bubola, Christina MacMillan, Ilan Weinreb, Ian Witterick, David Michael Swanson, Lei Zhang, Cristina R. Antonescu, Brendan Craig Dickson · 2021 · Head and Neck Pathology
  97. Establishment of Novel DNA Methylation-Based Prostate Cancer Subtypes and a Risk-Predicting Eight-Gene Signature
    Enchong Zhang, Fujisawa Shiori, Oscar Yong Nan Mu, Jieqian He, Yuntian Ge, Hongliang Wu, Mo Zhang, Yongsheng Song · 2021 · Frontiers in Cell and Developmental Biology
  98. IMPACT web portal: oncology database integrating molecular profiles with actionable therapeutics
    Jennifer D. Hintzsche, Minjae Yoo, Jihye Kim, Carol M. Amato, William Allen Robinson, Aik Choon Tan · 2018 · BMC Medical Genomics
  99. Predictive Biomarkers in Bladder Cancer
    Marwan Alkassis, Hampig Raphaël Kourié, Julien Sarkis, Elie Nemr · 2021 · Biomarkers in Medicine
  100. RNA Sequencing of Primary Cutaneous and Breast-Implant Associated Anaplastic Large Cell Lymphomas Reveals Infrequent Fusion Transcripts and Upregulation of PI3K/AKT Signaling via Neurotrophin Pathway Genes
    Arianna Di Napoli, Davide Vacca, Giorgio Bertolazzi, Gianluca Lopez, Maria Piane, Aldo Germani, Evelina Rogges, Giuseppina Pepe, Fabio Santanelli di Pompeo, Marzia Salgarello et al. · 2021 · Cancers